*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
"Screening for Ovarian Cancer: A Window into the Pelvis"
Michael A. Finan, M.D.
Director
Abraham A. Mitchell Chair USA Mitchell Cancer Institute
Despite advancements in ovarian cancer (OC) therapy, the greatest benefit in survival would be the discovery of an effective screening test that could accurately detect early-stage disease. I will discuss our efforts to develop a site-specific proteomic-based screening test for ovarian cancer using cervicovaginal fluid (CVL). Our initial results indicate that our test may be useful as a “triage” procedure to identify patients with cancer from those with a benign pelvic mass. Further testing is underway to evaluate the usefulness of the procedure as a general screening test for ovarian cancer.
